Mannatech (NASDAQ:MTEX) Earns Buy Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Mannatech (NASDAQ:MTEXFree Report) in a research report report published on Wednesday morning. The firm issued a buy rating on the stock.

Mannatech Stock Down 3.4 %

MTEX stock opened at $8.83 on Wednesday. The business has a 50 day moving average of $11.09 and a 200 day moving average of $10.06. The firm has a market cap of $16.64 million, a PE ratio of -10.90 and a beta of 1.06. Mannatech has a twelve month low of $6.75 and a twelve month high of $16.49. The company has a quick ratio of 0.74, a current ratio of 1.25 and a debt-to-equity ratio of 0.44.

Mannatech (NASDAQ:MTEXGet Free Report) last released its earnings results on Wednesday, March 26th. The company reported $1.20 EPS for the quarter. The firm had revenue of $29.01 million for the quarter. Mannatech had a negative return on equity of 15.62% and a negative net margin of 1.26%.

Mannatech Company Profile

(Get Free Report)

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.

Read More

Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.